Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 15 02:18PM ET
57.70
Dollar change
+0.44
Percentage change
0.77
%
Index- P/E- EPS (ttm)-2.72 Insider Own20.59% Shs Outstand57.83M Perf Week3.57%
Market Cap3.82B Forward P/E- EPS next Y-3.27 Insider Trans-0.63% Shs Float52.60M Perf Month1.83%
Income-149.65M PEG- EPS next Q-0.76 Inst Own65.71% Short Float13.78% Perf Quarter37.87%
Sales38.34M P/S99.69 EPS this Y2.99% Inst Trans-1.60% Short Ratio6.76 Perf Half Y83.11%
Book/sh5.95 P/B9.69 EPS next Y-12.41% ROA-35.78% Short Interest7.25M Perf Year120.39%
Cash/sh5.10 P/C11.32 EPS next 5Y-8.20% ROE-52.79% 52W Range19.81 - 61.61 Perf YTD109.81%
Dividend Est.- P/FCF- EPS past 5Y-18.50% ROI-41.65% 52W High-6.35% Beta1.11
Dividend TTM- Quick Ratio5.23 Sales past 5Y7.00% Gross Margin- 52W Low191.33% ATR (14)2.50
Dividend Ex-Date- Current Ratio5.23 EPS Y/Y TTM17.30% Oper. Margin-434.58% RSI (14)59.07 Volatility3.38% 4.54%
Employees229 Debt/Eq0.03 Sales Y/Y TTM-11.73% Profit Margin-390.36% Recom1.00 Target Price86.08
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q30.85% Payout- Rel Volume0.50 Prev Close57.26
Sales Surprise-17.72% EPS Surprise26.75% Sales Q/Q-41.56% EarningsMay 08 AMC Avg Volume1.07M Price57.70
SMA203.29% SMA5010.91% SMA20052.15% Trades Volume404,996 Change0.77%
Date Action Analyst Rating Change Price Target Change
Mar-28-24Initiated Truist Buy $69
Mar-04-24Reiterated Needham Buy $42 → $65
Nov-02-23Initiated Canaccord Genuity Buy $45
Aug-21-23Initiated TD Cowen Outperform
Aug-02-22Initiated Stifel Buy $38
Feb-11-22Initiated BMO Capital Markets Outperform $45
Feb-10-22Initiated Needham Buy $45
Nov-17-21Resumed Guggenheim Buy $44
Jun-07-21Upgrade Citigroup Neutral → Buy $24 → $31
Apr-08-21Initiated William Blair Outperform
Jul-08-24 08:00AM
Jul-01-24 08:00AM
Jun-03-24 02:30PM
Jun-02-24 12:30PM
May-29-24 09:30PM
08:00AM Loading…
08:00AM
May-28-24 04:01PM
07:00AM
May-27-24 11:37AM
May-24-24 04:05PM
03:41PM
01:31PM
12:00PM
08:47AM
07:16AM
07:01AM Loading…
07:01AM
May-23-24 05:00PM
05:00PM
11:51AM
May-17-24 12:50PM
May-13-24 09:58AM
08:00AM
May-09-24 12:53AM
May-08-24 04:15PM
May-06-24 04:05PM
Apr-26-24 07:58AM
Apr-25-24 10:01AM
Apr-24-24 10:00AM
Apr-08-24 12:00PM
Apr-03-24 08:00AM
10:11AM Loading…
Mar-06-24 10:11AM
08:00AM
06:15AM
Mar-05-24 04:30PM
Mar-04-24 08:00AM
Feb-28-24 04:15PM
Feb-20-24 10:00AM
Feb-16-24 03:57AM
Jan-31-24 08:00AM
Jan-09-24 05:07AM
Dec-28-23 09:55AM
Dec-12-23 09:55AM
Dec-05-23 12:00PM
Dec-04-23 12:15PM
Dec-02-23 08:40PM
Nov-26-23 11:05AM
Nov-23-23 09:55AM
Nov-07-23 09:55AM
Nov-02-23 04:12PM
Nov-01-23 08:00AM
Oct-31-23 10:01AM
Oct-26-23 10:02AM
Oct-23-23 07:30AM
Oct-17-23 05:00AM
Oct-15-23 07:58PM
Oct-13-23 09:00AM
Oct-06-23 09:32AM
Sep-11-23 03:45AM
Sep-07-23 07:36PM
Aug-31-23 08:00AM
Aug-21-23 09:44AM
Aug-09-23 09:53PM
04:01PM
Aug-07-23 07:15PM
04:26PM
Jul-28-23 08:00AM
Jul-05-23 04:01PM
Jun-29-23 04:30PM
Jun-28-23 07:35AM
Jun-15-23 07:47AM
May-31-23 08:00AM
May-21-23 03:28PM
May-11-23 12:00PM
May-10-23 09:55AM
May-05-23 10:24AM
May-04-23 08:15PM
04:25PM
May-02-23 10:01AM
May-01-23 10:00AM
Apr-17-23 10:15AM
Apr-14-23 11:10AM
11:10AM
Apr-10-23 10:16AM
Mar-14-23 04:30PM
04:30PM
09:08AM
Feb-28-23 04:25PM
Feb-23-23 11:37AM
Feb-20-23 10:00AM
Feb-15-23 06:22AM
Feb-10-23 03:44AM
Feb-01-23 08:00AM
Jan-28-23 01:30PM
Jan-19-23 11:06AM
05:37AM
Jan-09-23 06:05AM
Jan-08-23 09:00AM
Nov-09-22 08:00AM
07:09AM
Nov-03-22 09:05AM
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silverman Peter B.COO & GCJun 27 '24Option Exercise17.9410,000179,40010,000Jun 28 04:05 PM
Silverman Peter B.COO & GCJun 27 '24Sale60.0010,000600,0000Jun 28 04:05 PM
Silverman Peter B.COO & GCJun 17 '24Option Exercise24.3662,0001,510,28062,000Jun 20 04:30 PM
Silverman Peter B.COO & GCJun 17 '24Sale56.5262,0003,504,1780Jun 20 04:30 PM
Shuman HarryVP Controller, PAOJun 12 '24Sale57.847,300422,2327,002Jun 12 05:02 PM
Shuman HarryVP Controller, PAOJun 10 '24Sale53.221,00053,2247,002Jun 12 05:02 PM
Shuman HarryVP Controller, PAOJun 04 '24Sale52.896,000317,3547,002Jun 06 04:05 PM
Shuman HarryVP Controller, PAODec 19 '23Sale26.681153,0687,002Dec 20 04:05 PM
Silverman Peter B.COO & GCDec 15 '23Sale25.0022,386559,6500Dec 18 05:15 PM
Shuman HarryVP Controller, PAODec 08 '23Sale24.442506,1107,117Dec 12 04:04 PM
Shuman HarryVP Controller, PAODec 01 '23Option Exercise0.002,50007,942Dec 04 04:05 PM
Shuman HarryVP Controller, PAODec 01 '23Sale24.5857514,1337,367Dec 04 04:05 PM